Get the Stockscreener App
201.65
7.41%
13.36
Illumina Inc stock is traded at $201.65, with a volume of 1.24M.
It is up +7.41% in the last 24 hours and up +8.36% over the past month.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
See More
Previous Close:
$188.29
Open:
$193.51
24h Volume:
1.24M
Relative Volume:
0.66
Market Cap:
$30.45B
Revenue:
$4.39B
Net Income/Loss:
$853.00M
P/E Ratio:
36.60
EPS:
5.5097
Net Cash Flow:
$556.00M
1W Performance:
+4.84%
1M Performance:
+8.36%
6M Performance:
+68.54%
1Y Performance:
+99.06%
1-Day Range:
$192.68
$204.71
1-Week Range:
$187.44
$204.71
52-Week Range:
$88.00
$207.00
Illumina Inc Stock (ILMN) Company Profile
Name
Illumina Inc
Sector
Industry
Phone
(858) 202-4500
Address
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN vs TMO, DHR, NTRA, IDXX, A
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
201.65 | 28.43B | 4.39B | 853.00M | 556.00M | 5.5097 |
TMO
Thermo Fisher Scientific Inc
|
614.05 | 217.80B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
211.47 | 140.30B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
323.20 | 44.93B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
566.59 | 43.59B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
154.67 | 41.92B | 7.23B | 1.41B | 1.09B | 4.979 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-25 | Downgrade | Daiwa Securities | Outperform → Neutral |
| Jul-11-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Mar-04-25 | Reiterated | Citigroup | Neutral |
| Feb-28-25 | Downgrade | HSBC Securities | Buy → Hold |
| Feb-10-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Feb-07-25 | Downgrade | TD Cowen | Buy → Hold |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Nov-12-24 | Resumed | Morgan Stanley | Equal-Weight |
| Oct-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Aug-28-24 | Upgrade | Argus | Hold → Buy |
| Aug-16-24 | Upgrade | Daiwa Securities | Neutral → Buy |
| Aug-14-24 | Upgrade | Barclays | Underweight → Equal Weight |
| Aug-14-24 | Upgrade | TD Cowen | Hold → Buy |
| Jul-10-24 | Upgrade | Citigroup | Neutral → Buy |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Jan-16-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jan-04-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Dec-18-23 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Dec-15-23 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-14-23 | Initiated | Stephens | Overweight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Dec-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-11-23 | Upgrade | Citigroup | Sell → Neutral |
| Nov-10-23 | Downgrade | Canaccord Genuity | Buy → Hold |
| Sep-28-23 | Initiated | Bernstein | Underperform |
| Jul-05-23 | Resumed | JP Morgan | Neutral |
| Jan-25-23 | Downgrade | Argus | Buy → Hold |
| Jan-05-23 | Initiated | Scotiabank | Sector Perform |
| Dec-12-22 | Downgrade | Citigroup | Neutral → Sell |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-04-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Sep-28-22 | Upgrade | Evercore ISI | In-line → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Jul-13-22 | Downgrade | Barclays | Equal Weight → Underweight |
| Jan-18-22 | Upgrade | Stifel | Hold → Buy |
| Jan-11-22 | Upgrade | Barclays | Underweight → Equal Weight |
| Jan-07-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-06-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-19-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Jun-01-21 | Upgrade | Evercore ISI | Underperform → In-line |
| Mar-31-21 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Mar-31-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Mar-03-21 | Initiated | Barclays | Underweight |
| Dec-22-20 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-17-20 | Upgrade | BTIG Research | Neutral → Buy |
| Oct-13-20 | Downgrade | Guggenheim | Buy → Neutral |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-29-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-22-20 | Downgrade | Stifel | Buy → Hold |
| Sep-22-20 | Downgrade | UBS | Buy → Neutral |
| Sep-21-20 | Upgrade | Guggenheim | Neutral → Buy |
| Sep-21-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-09-20 | Initiated | Morgan Stanley | Equal-Weight |
| Aug-07-20 | Downgrade | Evercore ISI | In-line → Underperform |
| Aug-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-07-20 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-24-20 | Downgrade | Citigroup | Buy → Neutral |
| Apr-21-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Underweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-15-19 | Initiated | Stifel | Buy |
| Oct-25-19 | Initiated | Guggenheim | Buy |
View All
Illumina Inc Stock (ILMN) Latest News
Illumina Rallies as Investors Revisit Strong Q2 Results and Higher 2026 Outlook - Quiver Quantitative
Plato Investment Management Ltd Buys Shares of 5,423 Illumina, Inc. $ILMN - MarketBeat
Perigon Wealth Management LLC Buys Shares of 5,708 Illumina, Inc. $ILMN - MarketBeat
Illumina stock extends 2026 rally as analysts digest strong second-quarter beat - AD HOC NEWS
BlackRock Inc. Acquires Shares of 19,191,398 Illumina, Inc. $ILMN - MarketBeat
Did Illumina’s (ILMN) New Debt Deal and Credit Line Refresh Just Shift Its Investment Narrative? - simplywall.st
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Illumina stock holds above $190 as new $300 million notes add to its funding mix - ad-hoc-news.de
Illumina Stock Is Up 92% in a Year. Here’s What Analysts Are Saying. - TIKR.com
K.J. Harrison & Partners Inc Purchases New Holdings in Illumina, Inc. $ILMN - MarketBeat
Pallas Capital Advisors LLC Takes Position in Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. (NASDAQ:ILMN) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Illumina Raises $300M in New 2029 Notes to Repay Near-Term Debt - Minichart
Illumina Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Illumina sells $300M of 4.95% notes due 2029 to refinance maturing debt - TradingView
Weekly Recap: $300M notes due 2029 and heavy sequencing investment - TradingView
Old West Investment Management LLC Purchases New Stake in Illumina, Inc. $ILMN - MarketBeat
Oppenheimer Asset Management Inc. Purchases Shares of 9,498 Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. (ILMN) Stock Analysis: A Closer Look At Growth Potential And Market Position - DirectorsTalk Interviews
Diamond Hill Capital Management LLC Investment Advisor Makes New Investment in Illumina, Inc. $ILMN - MarketBeat
What is fake and what is real? Evaluating Illumina TruPath Genome in a research core facility - Illumina
S&CO Inc. Invests $3.16 Million in Illumina, Inc. $ILMN - MarketBeat
Focus Partners Advisor Solutions LLC Purchases Shares of 14,946 Illumina, Inc. $ILMN - MarketBeat
ILMN6480441 Latest News and Headlines - TradingView
Illumina STEM Scholars Program helps students imagine what’s next - Illumina
Illumina Secures $1 Billion Senior Unsecured Revolving Credit Facility with Five-Year Term - Kalkine Media
Form 8K Illumina Inc For: 13 August By Investing.com - Investing.com Nigeria
Illumina Secures $1.0 Billion Five-Year Revolving Credit Facility Led by Bank of America - TradingView
Illumina, Inc. Enters into $1,000 Million Senior Unsecured Five-Year Revolving Credit Facility - marketscreener.com
ILMN6480441 Bond Profile — Key Metrics - TradingView
ILMN6480441 Bond Yield and Price — FINRA:ILMN6480441 - TradingView
Illumina Announces $300 Million Senior Notes Offering - The Globe and Mail
Illumina, Inc. (ILMN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Illumina stock steadies as $300 million note deal follows earnings beat - AD HOC NEWS
Illumina Announces $300 Million 4.95% Notes Offering Maturing in 2029 - Kalkine Media
Illumina announces $300 million note offering to refinance existing debt By Investing.com - Investing.com South Africa
Form 8K Illumina Inc For: 12 August By Investing.com - Investing.com South Africa
Illumina announces $300 million note offering to refinance existing debt - Investing.com
Illumina prices $300M of 4.950% notes due 2029 to refinance Sept. 2026 debt - tradingview.com
Illumina (ILMN) plans $300M 4.950% notes due 2029 to refinance 2026 debt - Stock Titan
32,967 Shares in Illumina, Inc. $ILMN Bought by Insight Wealth Strategies LLC - MarketBeat
Illumina (ILMN) Is Up 5.7% After Raising 2026 Revenue Guidance and Q3 Outlook - Sahm
Old West Investment Management, LLC's Illumina Inc(ILMN) Holding History - GuruFocus
Illumina Building Clinical Momentum Amid Fading Competition, RBC Capital Markets Says - marketscreener.com
The Zacks Analyst Blog Highlights Illumina, Qnity Electronics and nVent Electric - Yahoo Finance
Illumina Inc (ILMN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina Stock Is Up 40% Since January. Should You Still Ride the Wave in 2026? - TIKR.com
Illumina, Inc. (ILMN) Stock Analysis: Navigating Potential Upside In Genomic Innovation - DirectorsTalk Interviews
Assenagon Asset Management S.A. Grows Holdings in Illumina, Inc. $ILMN - MarketBeat
ETFs Investing in Illumina, Inc. Stocks - TradingView
Illumina Inc Stock (ILMN) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):